Introduction
The morphology and distribution of mitochondria differ significantly between the cells of different species and tissues. In addition, mitochondrial volume and morphology vary in function of cellular metabolism, are modulated during cell cycle and development and modified during apoptosis (Stevens, 1981; Tzagoloff, 1982; Bereiter-Hahn and Voth, 1994; Church and Poyton, 1998; Diaz et al., 1999; Frank et al., 2001) . Live microscopy has revealed that mitochondrial morphology is continuously remodeled by fission and fusion (Nunnari et al., 1997; Rizzuto et al., 1998) . In yeast, selective inhibition of either process significantly modifies mitochondrial size and interconnectivity (Bleazard et al., 1999; Sesaki and Jensen, 1999) . Among the best known proteins involved in mitochondrial dynamics are Fzo/mitofusin, a transmembrane GTPase involved in fusion (Hales and Fuller, 1997; Hermann et al., 1998; Santel and Fuller, 2001; Rojo et al., 2002) , and Dnm1p/Dlp1/Drp1, a dynamin-related protein involved in fission (Bleazard et al., 1999; Pitts et al., 1999; Smirnova et al., 2001 ).
In yeast, mitochondrial fusion has been demonstrated by the diffusion and/or mixing of different matrix proteins during mating of haploid cells (Azpiroz and Butow, 1993; Nunnari et al., 1997) . In contrary, mitochondrial fusion has not been studied with similar assays in human cells and it is not known to what extent the apparent fusion events observed by live microscopy correspond to the formation of intermitochondrial junctions (Bakeeva et al., 1978; Amchenkova et al., 1988) , to outer membrane fusion or to complete fusion of double membranes. In addition, we ignore the extent, kinetics and requirements of fusion and fission, which determine the degree of mitochondrial interconnectivity and the efficiency of molecular exchanges between mitochondria.
The available reports are contradictory on the nature of this compartment: mitochondria have been reported (1) to exist as independent and heterogeneous organelles, (2) to belong to 4 functionally different mitochondrial (sub)populations and (3) to form interconnected mitochondrial network(s) (Bakeeva et al., 1978; Amchenkova et al., 1988; Rizzuto et al., 1998; De Giorgi et al., 2000; Park et al., 2001; Collins et al., 2002) . The connection between mitochondrial filaments is highly relevant for mitochondrial function, as it allows energy transmission between different cellular regions (Amchenkova et al., 1988) and determines the size and dynamics of the mitochondrial Ca 2+ pool(s) (Rizzuto et al., 1998; De Giorgi et al., 2000; Park et al., 2001; Collins et al., 2002) . In addition, the efficacy of fusion-mediated exchanges governs the complementation between mitochondrial DNA (mtDNA) molecules.
Numerous mtDNA mutations have been described in association with human diseases. Most of them are heteroplasmic, i.e. mutated mtDNA-molecules co-exist with wild type ones within one cell. The severity of these diseases depends on the amount of wild type mtDNA which, above a relatively low threshold, permits normal mitochondrial activity and clinical presentation (reviewed in (Shoubridge, 1994; Lightowlers et al., 1997) ). Complementation between normal and mutant mtDNA requires molecular exchanges between mitochondria and therefore efficient mitochondrial fusion. Evidence for mtDNA complementation and recombination has been found in the budding yeast (Dujon, 1981) , but complementation in mammals is the matter of debate. According to contradicting reports, complementation between different mtDNA-mutants is either rare (Enriquez et al., 2000) or requires 10-14 days to become efficient . These reports indicate that mitochondrial fusion in mammalian cells may be rare or slow, or not accompanied by molecular exchanges.
Here we demonstrate that mitochondrial fusion mediates the efficient exchange of soluble matrix proteins and modulates mitochondrial size and morphology in human cell lines. Fusion proceeds in the absence of a functional respiratory chain and after significant ATP-depletion, but is abolished by dissipation of the inner membrane potential. Inhibition of fusion results in rapid (≤ 4 h) fragmentation of mitochondria by Drp1-mediated fission. Repolarization of the 5 inner membrane restores mitochondrial fusion and leads to rapid reformation of mitochondrial filaments. We further show that the stimulation of mitochondrial fusion by a human mitofusin leads to increased mitochondrial interconnectivity.
Materials and methods

Reagents
Carbonyl cyanide m-chlorophenyl hydrazone (cccp), carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (fccp), oligomycin and trichostatin A were obtained from Sigma, WGAAlexaFluor 350 from Molecular Probes, G418 from Gibco Life Technologies, polyethylene glycol (PEG) 1500 from BDH and staurosporine from Alexis Biochemicals. The stock solutions of cccp (10 mM in DMSO), deoxyglucose (2M in DMEM without glucose), fccp (10 mM in DMSO), oligomycin (1 mg/ml in ethanol) and trichostatin A (1 mM in DMSO)
were stored at -20°C. The stock solution of staurosporine (1 mM in DMSO) was stored at 4°C. All other substances were obtained and handled as described (Bakker et al., 2000; Rojo et al., 2000; Rojo et al., 2002) .
Cloning and mutagenesis
Cloning was performed according to standard procedures and all PCR products were verified by sequencing. Cloning of mitofusins Mfn1 and Mfn2 and of mtGFP has been described (Rojo et al., 2002) . A version of the red fluorescent protein DsRed1 (RFP) targeted to the mitochondrial matrix (mtRFP) was constructed as described for mtGFP (Rojo et al., 2002) .
The cDNA encoding human Drp1 (Accession number AF000430: bases 73-2283) was amplified by RT-PCR from total RNA of human skin fibroblasts using Superscript II RT (Gibco Life Technologies) and Expand High Fidelity polymerase (Roche Molecular Biochemicals). The PCR-primers were appended with restriction sites and the restrictiondigested PCR product was cloned into pCB6 (Rojo et al., 2000) . The G1-motif of Drp1 was mutated (K38A) with Quikchange (Stratagene). Expression plasmids encoding HA-tagged OMP25 and a GFP-molecule targeted to the mitochondrial outer membrane with the transmembrane domain of OMP25 (GFPOM) (Nemoto and De Camilli, 1999) were kindly provided by Pietro De Camilli.
Cell culture and transfection
HeLa cells and osteosarcoma cells 143B and 143B-ρ0 were maintained as described (Bakker et al., 2000; Rojo et al., 2000) . Cells were transfected with the calcium phosphate technique (Jordan et al., 1996) and stable transfectants expressing mtGFP or mtRFP were obtained by selection with G418 (0.6 mg/ml). Stably-transfected clones of HeLa and 143B ρ0-cell were incubated with 1µM trichostatin A during 24-48 hours to increase mtGFP expression (see for example (Shima et al., 1997; Condreay et al., 1999) ). Trichostatin A was removed from the medium 12-24 hours before PEG-mediated cell fusion to avoid other effects of trichostatin A (aberrant morphology, cell cycle arrest and/or apoptosis: (Hoshikawa et al., 1994; Medina et al., 1997) ). Cells maintained high mtGFP-levels and reacquired a normal morphology within this time period. In transient transfection experiments, cells were fixed 30-48 hours after addition of DNA. To ensure the co-expression of Drp1 and Drp1K38A in mtGFP-labeled cells (Fig. 6 ), the plasmids encoding Drp1 molecules were transfected in a three-fold excess (4.5 µg pCB6-Drp1/Drp1K38A and 1.5 µg pCB6-mtGFP per 35 mm well). In all other experiments, plasmids were co-transfected in equal amounts (2 µg of each plasmid per 35 mm well). Unless otherwise indicated, drugs and dyes were added to cells at the following concentrations: 10 µM cccp, 20 µg/ml cycloheximide, 40 mM deoxyglucose, 5 µM fccp, 5 µg/ml JC-1, 2.5 µM oligomycin, 0.2 µM rotenone, 1µM staurosporine. A medium containing pyruvate but devoid of glucose was used for deoxyglucose treatment. All other drugs were added to standard culture medium.
Cell fusion
For cell fusion, cells carrying differently labeled mitochondria were mixed and plated on glass coverslips 16 to 40 hours before cell fusion. Cycloheximide (20 µg/ml) was added 30 minutes before fusion and kept in all solutions used subsequently to inhibit protein synthesis (see below). The protocol for PEG-mediated fusion of adherent cells (Borer et al., 1989) The ability of cycloheximide to inhibit protein synthesis was determined by measuring the incorporation of 35 S-Met/Cys into proteins precipitated with methanol/chlorophorm (Wessel and Flugge, 1984) . Cycloheximide (20 µg/ml or 100 µg/ml) inhibited ~90% or ~95% protein synthesis both in HeLa and in 143B cells. The total amount of mtGFP and mtRFP was determined after cell trypsinization and solubilization in a Kontron SFM25 fluorimeter by measuring GFP/RFP-fluorescence (excitation/emission: GFP = 473/509 nm, RFP = 558/583).
Inhibition of 90% protein synthesis with 20 µg/ml cycloheximide for 4 hours decreased 9 cellular GFP or RFP fluorescence by ~10 or ~2 %, respectively. This indicates that after a 4 hour period only ~2-10% of the total GFP/RFP fluorescence originates from neosynthesis. In a standard four hour fusion experiment, when 90% of protein synthesis is inhibited with 20 µg/ml cycloheximide, the proportion of newly synthesized mtGFP/mtRFP represents ~0.2-1 % of total mtGFP/mtRFP content.
Antibodies, immunohistological staining and fluorescence microscopy
Antibodies against tubulin (1A2) were a gift of Thomas Kreis and antibodies against the myc (9E10) and HA (HA.11) epitopes were obtained from Eurogentec. Antibodies against Mfn2 have been described (Rojo et al., 2002) . For improved co-visualization of myc-tagged mitofusins and HA-OMP25 with mtGFP or mtRFP, cells were shortly fixed with paraformaldehyde (3% w/v, 5 min) and permeabilized with cold methanol (-20°C, 5 min) as described (Rojo et al., 2002) . All other immunohistochemical stainings were performed on cells fixed with paraformaldehyde (3% w/v, 20 min) and permeabilized with 0.1% Triton X-100 (5 min) as previously described (Rojo et al., 1997) . 
Results
Mitochondria fuse and exchange soluble matrix proteins
To investigate mitochondrial fusion with an assay based on content-mixing, we generated stably transfected human HeLa cells expressing green or red fluorescent proteins targeted to the mitochondrial matrix (mtGFP, mtRFP). Cells with differently labeled mitochondria were fused with polyethylene glycol (PEG) in the presence of cycloheximide to inhibit protein synthesis (see Materials and Methods). Cytoplasmic fusion became apparent by phase contrast microscopy after 30-45 min and polykaryons were readily observed after 3-4 hours.
Preliminary experiments had shown that mitochondrial morphology and distribution were not affected by PEG-mediated cell fusion or by treatment with cycloheximide. The mitochondrial inner membrane potential (∆Ψm) was also unaffected by these treatments, as indicated by the red fluorescence of the potential-sensitive dye JC-1 (data not shown (Smiley et al., 1991) ).
Two hours after cell fusion, double-labeled mitochondria ( requisite for complementation, it has been speculated that the differences between "rarely complementing" 143B cells (Enriquez et al., 2000) and "complementing" HeLa cells could arise from differences in the nuclear background and the machineries available for intermitochondrial fusion and/or complementation. To investigate this hypothesis, we generated 143B cells stably expressing mtGFP or mtRFP. We observed that mitochondria of 143B cells also fuse and exchange fluorescent matrix proteins (data not shown), demonstrating that mitochondrial fusion is not specific to a particular human cell line.
A functional respiratory chain is dispensable for mitochondrial fusion
Studies on intermitochondrial complementation have been performed with respirationdeficient cell lines devoid of mtDNA (ρ0-cells) or with ρ0-derived cells that had been repopulated with mutant mtDNA from patients (Enriquez et al., 2000; Ono et al., 2001) . To investigate whether a functional respiratory chain is necessary for mitochondrial fusion, we generated 143B-ρ0 cells stably expressing mtGFP or mtRFP. The mitochondria of 143B-ρ0 cells often contained a higher proportion of short and/or punctate mitochondria than HeLa and 143B cells (Fig. 1D-F) . Four hours after cytoplasmic fusion, fused (double-labeled) and nonfused (single-labeled) mitochondria co-existed within polykaryons, the different distributions of mtGFP and mtRFP indicating the original label and position of the fused cells (Fig. 1D, E ).
In contrast, 16 hours after cytoplasmic fusion, mitochondria were homogeneously doublelabeled (Fig. 1F) . To estimate the efficiency and kinetics of mitochondrial fusion, the proportion of double-labeled mitochondria was determined on polykaryons fixed at different times after PEG-treatment. Both in HeLa cells and in 143B-ρ0 cells, mitochondrial fusion appears as an efficient process that progresses linearly with time, reaches 70% content mixing after 8 hours and is predicted to mediate full content-mixing after 10-12 hours (Fig. 2 ). These results demonstrate that mitochondrial fusion proceeds equally well in respiratory-competent HeLa cells and in respiratory-deficient 143B-ρ0 cells and thus, that a functional respiratory chain is dispensable for mitochondrial fusion.
The inner membrane potential is required for mitochondrial fusion
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The observation that respiration-deficient and respiration-competent mitochondria fuse with similar kinetics was relatively unexpected, because mitochondrial fusion most probably represents an energy-dependent process. Since the available clones of ρ0-cells (HeLa-ρ0 and 143B-ρ0) maintain an inner membrane potential (∆Ψm) that allows the import of nuclearencoded proteins and the maintenance of several mitochondrial functions (Buchet and Godinot, 1998), we used specific inhibitors of energy metabolism to investigate the energetic requirements of mitochondrial fusion. We used (1) oligomycin to inhibit the mitochondrial ATP-synthetase, (2) the protonophore carbonyl cyanide m-chlorophenyl hydrazone (cccp) to dissipate the ∆Ψm and inhibit mitochondrial ATP-synthesis and (3) deoxyglucose to sequester cytosolic ATP, block the glycolytic pathway and inhibit cytosolic ATP synthesis.
After a 45 min treatment, oligomycin and cccp had lowered cellular ATP levels by 20%, deoxyglucose by 60% and a combined treatment with oligomycin and deoxyglucose by 80% (Fig. 3A) . In contrast, withdrawal of glucose alone did not lower the cellular ATP content.
Measurement of ∆Ψm with the JC-1 dye (Smiley et al., 1991) showed that oligomycin led to a slight increase in ∆Ψm and that cccp induced significant depolarization of the inner membrane (Fig. 3A) ; the other treatments were without effect or even led to an increase of JC-1 fluorescence (Fig. 3A) . To further investigate the toxicity of these drugs, cells were visualized by phase-contrast microscopy. Overall cell morphology was unaffected after 45 min, but differences were clearly visible after 3 hours. In contrast to control cells and to cells treated with cccp or oligomycin, deoxyglucose-treated cells appeared to retract (Fig. 3B) . The combined treatment with deoxyglucose and oligomycin provoked massive cell detachment after 1-2 hours, leading to the absence of adherent cells after 3 hours (Fig. 3B) . None of these treatments provoked the apoptotic morphology observed upon treatment with 1µM staurosporine (Fig. 3B) . The relatively low toxicity of mitochondria-specific drugs was confirmed by the observation that cccp-treated cells remained viable for up to 24 h and that 13 their mitochondria retained cytochrome c (data not shown), as described earlier (Lim et al., 2001) .
We then performed the assay of mitochondrial fusion in the presence of cccp, deoxyglucose or oligomycin. Cells expressing mtGFP or mtRFP were pre-incubated with the respective drugs for 30 min, fused with PEG and fixed after further four hours in drug-containing medium. Mitochondrial tubules were shorter and numerous mitochondria appeared as punctate structures, especially upon incubation with cccp (Fig. 4) . In the presence of cccp, differently labeled mitochondria were mixed in the central region of the polykaryon (Fig. 4A: box 1) and a few red mitochondria had moved to the region of the polykaryon containing green mitochondria ( (data not shown) or oligomycin ( Fig. 4B ) than in control cells (Fig. 1) . Altogether, these data demonstrate that mitochondrial fusion can proceed after significant reduction of cellular ATPlevels (with oligomycin or deoxyglucose), but that dissipation of ∆Ψm (with cccp) leads to complete inhibition of mitochondrial fusion.
It has been reported that protonophores uncoupling oxidation from phosphorylation disrupt microtubules in cultured human cells, (Maro and Bornens, 1982) . We therefore investigated whether cccp-mediated mitochondrial fragmentation (Fig. 4A ) was a direct consequence of inner membrane depolarization (and fusion inhibition) or a secondary effect of microtubuledisruption. HeLa cells expressing mtRFP were treated with cccp or with the microtubule-14 disrupting agent nocodazole and tubulin was subsequently visualized with specific antibodies.
Incubation with cccp led to mitochondrial fragmentation, but not to disruption of microtubules (Fig. 5: cccp) . In contrast, treatment with 10 µM nocodazole led to depolymerization of microtubules and to the disorganization of the mitochondrial network, but not to fragmentation of mitochondrial filaments (Fig. 5: nocodazole) . These results show that in HeLa cells, mitochondrial fragmentation is a direct consequence of fusion-inhibition. The fragmentation of mitochondria by oligomycin ( Fig. 4B and see below Fig. 6A ) and deoxyglucose (data not shown) suggest that the rate of fusion is lowered upon ATP-depletion.
It is noteworthy that the inhibition of fusion (by inactivation of temperature-sensitive Fzo1p) also leads to mitochondrial fragmentation in yeast (Hermann et al., 1998; Rapaport et al., 1998) .
Inhibition of fusion triggers Drp1-mediated fragmentation and is reversed upon repolarization of the inner membrane
We then investigated whether mitochondrial fragmentation is due to ongoing mitochondrial division, a process mediated by dynamin-related protein 1 (Drp1) in mammals. To this end, cells were transfected with either wild-type Drp1 or a dominant-negative mutant of Drp1 (Drp1K38A) that inhibits Drp1-function (Smirnova et al., 2001) . Mitochondria displayed their normal tubular morphology in cells transfected with wild type Drp1 (Fig. 6A: control) . In contrast, mitochondrial length and connectivity were slightly higher in cells transfected with Drp1K38A ( Fig. 6B: control) . The two types of transfected cells were treated during 4 hours with cccp, oligomycin or deoxyglucose. The mitochondrial fragmentation normally induced by these treatments also occurred in cells expressing the wild type Drp1 (Fig. 6A) . In contrast, mitochondrial fragmentation was inhibited in cells expressing dominant negative Drp1K38A (Fig. 6B) . This demonstrates that, upon inhibition of fusion, mitochondrial filaments are fragmented by Drp1-mediated fission.
Since the inner mitochondrial membrane reacquires a normal ∆Ψm after cccp-removal, we investigated whether fusion-inhibition by cccp was also reversible. Live microscopy revealed that, upon removal of cccp, punctate mitochondria fuse and form tubules (online supplemental material, movie 2). Indeed, mitochondria reacquired their normal filamentous morphology, which is indistinguishable from those of control cells, 4 hours after cccp-washout ( Fig. 6C: control). The capacity of punctate mitochondria to fuse and form filaments upon cccpremoval allowed us to investigate the requirements of mitochondrial fusion more precisely. 
The stimulation of mitochondrial fusion by mitofusin 1 requires the inner membrane potential
The proteins known to directly participate in mitochondrial fusion (Fzo1p/Mfn and Ugo1p) localize to the mitochondrial outer membrane (Rapaport et al., 1998; Sesaki and Jensen, 2001; Rojo et al., 2002) . To investigate whether and how the activity of such outer membrane proteins is modulated by the inner membrane potential, we studied Mfn1, a mammalian Fzohomolog that has not been characterized yet (Santel and Fuller, 2001; Rojo et al., 2002) . Upon expression, myc-tagged Mfn1 was targeted to mitochondria, where it colocalized with mtGFP (data not shown) and severely modified mitochondrial morphology and distribution. In HeLa cells, expression of Mfn1 led to the appearance of mitochondria that were frequently branched and interconnected, even at the cell periphery ( Fig. 7B : HeLa). Mfn1-expression also increased the length and interconnectivity of mitochondria in COS7 cells (Fig. 7B: COS7) . In numerous cells, mitochondrial filaments tended to accumulate in the perinuclear region and long mitochondrial tubules grew out of such mitochondrial bundles (Fig. 7B) . These mitochondrial profiles differ significantly from those observed upon fission-inhibition with Drp1K38A ( Fig. 6B) . At very high expression levels, Mfn1 led to mitochondrial clustering ( Fig. 7B : arrowhead), as described previously for Mfn2 (Santel and Fuller, 2001; Rojo et al., 2002) . Close analysis of Mfn2-transfectants also revealed cells with elongated and branched mitochondria, but their proportion was very low (data not shown). To investigate the specificity of the profiles induced by excess Mfn1, we expressed two other outer membrane proteins: OMP25, a protein that can cluster mitochondria via its PDZ domain and GFPOM, a GFP-molecule targeted to mitochondria by the transmembrane domain of OMP25 (Nemoto and De Camilli, 1999) . Neither protein induced the appearance of elongated and interconnected mitochondria (data not shown), demonstrating that the capacity to increase the length and interconnectivity of mitochondria is specific for Mfn1. The co-expression of Mfn1 and Mfn2 did not change the morphologies and frequencies of Mfn-specific profiles (Fig. 7C ).
Immunofluorescence with antibodies against the myc-tag and with antibodies against the Nterminal domain of Mfn2 (Rojo et al., 2002) , revealed that mitofusins colocalize on elongated and interconnected filaments as well as on clustered mitochondria (Fig. 7C ). This indicates that it is not the absence of equivalent amounts of Mfn1 and Mfn2 that limits the appearance of elongated and branched mitochondria and/or provokes mitochondrial clustering.
The disappearance of punctate mitochondria and the increase in mitochondrial length and interconnectivity suggest that excess Mfn1 stimulates fusion. To investigate this hypothesis, we analyzed the influence of ∆Ψm on this process. Cells were transfected with Mfn1 and 17 mtGFP and cccp was added either 9 hours after transfection (before expression of exogenous proteins, Fig. 7D ) or 36 hours after transfection (after Mfn1-overexpression, Fig. 7E ). In both cases, cells were fixed and analyzed by immunofluorescence 40 hours after transfection. In the absence of ∆Ψm, mtGFP behaved like a matrix protein (Neupert, 1997) and remained cytosolic (data not shown) while Mfn1 behaved as an outer membrane protein (Shore et al., 1995) and was targeted to mitochondria (Fig. 7D) . Mfn1 retained the capacity to cluster mitochondria at high expression levels, but did not mediate the apparition of elongated and interconnected mitochondrial filaments (Fig. 7D) . The inhibition of fusion (for 4 hours) in cells that had been expressing Mfn1 (for 36 hours) led to the disappearance of elongated and interconnected mitochondria, but not to the dissociation of mitochondrial clusters (Fig. 7E ).
These results show that Drp1-mediated mitochondrial division remains active in Mfn1-transfected cells and thus, that Mfn1 increases mitochondrial length and interconnectivity by the stimulation of ∆Ψm-dependent fusion.
Discussion
The capacity of mitochondria to exchange soluble matrix proteins demonstrates that mitochondria fuse with each other by the merging of inner and outer mitochondrial membranes. The complete exchange of matrix proteins by fusion shows that mitochondrial fusion is efficient, and that the mitochondrial matrix represents a single cellular compartment.
The mitochondria of the HeLa cells used in this work appeared as long and interconnected filaments, in agreement with the work of others (Rizzuto et al., 1998; De Giorgi et al., 2000) .
The smaller size of HeLa mitochondria in other reports (Collins et al., 2002) , may be related to the fact that HeLa cells have diverged into sublines since the establishment of the founder "uncloned" HeLa cells (Herrnstadt et al., 2002) . We found that mitochondrial fusion also occured in 143B and 143B-ρ0 cells and was therefore not restricted to a particular cell line.
Furthermore, the kinetics of intermitochondrial fusion were similar in HeLa cells and in 143B-ρ0 cells, which are devoid of a functional respiratory chain and posses significantly smaller mitochondria. Nevertheless, the fact that complete intermixing of matrix contents required 10-12 hours indicates that mitochondrial fusion is a relatively slow process. Separate mitochondria will thus remain heterogeneous and behave as independent entities during shorter time periods, as reported (Park et al., 2001; Collins et al., 2002) .
We have demonstrated that dissipation of the inner membrane potential inhibits mitochondrial fusion. Protonophores did not affect the microtubule network, probably because they were used at lower concentrations (10 µM cccp) than in other studies (30 µM fccp: (Maro and Bornens, 1982) ). The mechanisms by which inner membrane depolarization inhibits fusion remain to be determined. The inhibition of mRNA translation with cycloheximide, which blocks synthesis of nuclear-encoded mitochondrial proteins, did not impede mitochondrial fusion. Therefore, it is probably not the inhibition of protein import to the matrix and inner membrane that hampers mitochondrial fusion. It is possible that the ∆Ψm is required by yet unknown proteins to catalyze the fusion of the inner membrane, maybe via ∆Ψm-dependent conformational changes. Alternatively, dissipation of ∆Ψm may induce modifications of mitochondrial structure that inhibit the function or the coordination of the fusion machinery.
Indeed, changes in the energetic state of mitochondria induce severe modifications in the matrix compartment (Hackenbrock, 1968) and affect the size and frequency of contact sites between the inner and outer mitochondrial membranes (Knoll and Bridczka, 1983; Biermans et al., 1990) . Interestingly, yeast Fzo1p is enriched in contact sites and mutant Fzo1p-molecules that fail to enrich in contact sites loose the capacity to mediate fusion (Fritz et al., 2001 ).
Mitochondrial fusion was abolished upon dissipation of ∆Ψm and partially inhibited by treatments that lowered ATP-levels. It is thus possible that kinetics and efficiency of mitochondrial fusion are modulated in vivo by ∆Ψm and/or ATP level. We found that the proportion of mitochondrial energy supply is relatively low in cultured HeLa cells (around 20%), in contrast to aerobic tissues in vivo, where mitochondrial respiration is the major source of ATP (Tzagoloff, 1982) . The dependence of mitochondrial fusion on ∆Ψm and ATPlevel indicates that its efficiency may be lowered in tissues of patients with mitochondrial diseases (Leonard and Schapira, 2000a, b) . This may explain why complementation by wildtype mtDNA is hampered at high doses of mutant mtDNA in vivo (Boulet et al., 1992; Nakada et al., 2001) . In contrast, fusion capacity should not be affected in clones of ρ0-cells repopulated with mutant mtDNA (Bakker et al., 2000; Enriquez et al., 2000; Ono et al., 2001 ), because they are expected to maintain a ∆Ψm similar to that of parental ρ0-cells (Buchet and Godinot, 1998) . Therefore, mitochondrial fusion should not be the limiting factor for functional complementation between mitochondria carrying different mutants of mtDNA.
Further studies are necessary to identify and understand the factors that render complementation rare (Enriquez et al., 2000) or relatively slow . They may 20 be the diffusion and exchange of complementing molecules (mtDNA, RNAs and membrane proteins) and/or the synthesis and assembly of functional respiratory complexes.
The ability to specifically inhibit fusion (by dissipation of ∆Ψm) or fission (by expression of dominant negative Drp1K38A) and the changes induced by these treatments demonstrated that, also in mammals, mitochondrial morphology is determined by the balance of both reactions. The variability of mitochondrial length and interconnectivity in different cells and tissues probably reflects differences in the relative rates of fusion and fission. In yeast, this balance is maintained by the constitutive activity of Fzo1p and Dnm1p (Bleazard et al., 1999; Sesaki and Jensen, 1999) . The efficacy of mitochondrial fusion in cultured cells, the ubiquitous expression of mitofusins (Rojo et al., 2002) and the filamentous morphology of mitochondria in several tissues (Tzagoloff, 1982) suggest that mitochondrial fusion is a constitutive and ubiquitous process in mammals. Nevertheless, it may well be that the inhibition of fusion or the stimulation of fission provokes mitochondrial fragmentation during certain stages of development and of the cell cycle. This would have important consequences for the transmission, segregation and/or fixation of heteroplasmic mtDNA, the mechanisms of which are largely unknown (Lightowlers et al., 1997) . The disintegration of mitochondrial filaments by Drp1 is also observed during apoptosis (Frank et al., 2001) . Our findings also predict that mitochondrial fusion is inhibited during apoptosis, when the opening of the permeability transition pore dissipates ∆Ψm (Bernardi et al., 2001) . Further work will be necessary to investigate the relative contributions of stimulated fission and/or inhibited fusion to the fragmentation of mitochondria during apoptosis.
In contrast to Mfn2, which mediates massive clustering of mitochondria (Santel and Fuller, 2001; Rojo et al., 2002) Mfn2 may have a higher capacity to cluster mitochondria (and mask stimulated fusion) or a lower ability to stimulate fusion. Alternatively, overexpression of mitofusin(s) alone may not be sufficient to increase the activity the fusion machinery, which probably involves numerous proteins. Further work is necessary to understand mitochondrial fusion and whether and how it resembles membrane fusion in other systems (Jahn and Südhof, 1999; Heiman and Walter, 2000; Peters et al., 2001) . 
